RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Alligator Bioscience Stock

Alligator Bioscience Net Income 2024

Alligator Bioscience Net Income

-117.12 M SEK

Ticker

ATORX.ST

ISIN

SE0000767188

WKN

A2AN1Z

In 2024, Alligator Bioscience's profit amounted to -117.12 M SEK, a -52.89% increase from the -248.59 M SEK profit recorded in the previous year.

The Alligator Bioscience Net Income history

YEARNET INCOME (undefined SEK)
2026e-39.04
2025e-70.27
2024e-117.12
2023-248.59
2022-193.4
2021-141.74
2020-143.3
2019-210.11
2018-150.04
2017-63.76
2016-48.36
2015207.38
2014-76.78

Alligator Bioscience Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Alligator Bioscience, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Alligator Bioscience from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Alligator Bioscience’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Alligator Bioscience. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Alligator Bioscience’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Alligator Bioscience’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Alligator Bioscience’s growth potential.

Alligator Bioscience Revenue, EBIT and net profit per share

DateAlligator Bioscience RevenueAlligator Bioscience EBITAlligator Bioscience Net Income
2026e120 M SEK-37.6 M SEK-39.04 M SEK
2025e118.97 M SEK-74.16 M SEK-70.27 M SEK
2024e245.14 M SEK-19.57 M SEK-117.12 M SEK
202358.11 M SEK-249.39 M SEK-248.59 M SEK
202235.7 M SEK-192.3 M SEK-193.4 M SEK
202112.94 M SEK-141.36 M SEK-141.74 M SEK
20204.35 M SEK-144.04 M SEK-143.3 M SEK
20194.36 M SEK-213.17 M SEK-210.11 M SEK
201826.96 M SEK-152.18 M SEK-150.04 M SEK
201756.88 M SEK-63.03 M SEK-63.76 M SEK
201658.24 M SEK-33.96 M SEK-48.36 M SEK
2015289.8 M SEK213.09 M SEK207.38 M SEK
20140 SEK-77.21 M SEK-76.78 M SEK

Alligator Bioscience stock margins

The Alligator Bioscience margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Alligator Bioscience. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Alligator Bioscience.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Alligator Bioscience's sales revenue. A higher gross margin percentage indicates that the Alligator Bioscience retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Alligator Bioscience's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Alligator Bioscience's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Alligator Bioscience's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Alligator Bioscience. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Alligator Bioscience's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Alligator Bioscience Margin History

Alligator Bioscience Gross marginAlligator Bioscience Profit marginAlligator Bioscience EBIT marginAlligator Bioscience Profit margin
2026e-312.98 %-31.33 %-32.53 %
2025e-312.98 %-62.34 %-59.07 %
2024e-312.98 %-7.98 %-47.78 %
2023-312.98 %-429.19 %-427.81 %
2022-312.98 %-538.7 %-541.81 %
2021-569.03 %-1,092.18 %-1,095.08 %
2020-312.98 %-3,309.65 %-3,292.65 %
2019-312.98 %-4,891.46 %-4,821.29 %
2018-312.98 %-564.49 %-556.56 %
2017-312.98 %-110.82 %-112.1 %
2016-312.98 %-58.31 %-83.03 %
2015-312.98 %73.53 %71.56 %
2014-312.98 %0 %0 %

Alligator Bioscience Aktienanalyse

What does Alligator Bioscience do?

Alligator Bioscience AB is a biopharmaceutical company based in Lund, Sweden. The company was founded in 2001 and specializes in the development of innovative cancer therapies that harness the body's immune system to fight tumor cells. The company's business model is based on the research, development, and commercialization of biological drugs using highly specialized technologies such as antibody research and immuno-oncology. Alligator Bioscience works closely with leading research institutions and partners in the biotechnology and pharmaceutical industries. Its main focus is on developing antibodies against cancer using its patented technology platforms ALLIGATOR-GOLD® and ALLIGATOR-FAB®. These antibodies are highly effective, safe, and have a low side effect profile. Another important area of Alligator Bioscience's work is immuno-oncology, which involves activating and enhancing the body's own immune system to target and destroy cancer cells. The company has developed a range of innovative drugs in various stages of clinical development. One of its key products is ATOR-1017, a monoclonal antibody that targets the OX40 T-cell receptor and has shown promising results in activating the immune system against cancer in clinical trials. ADC-1013, an antibody targeting the PD-1 receptor, is another promising drug in development for the treatment of various types of cancer. Alligator Bioscience has a diverse portfolio of products and drugs focused on fighting cancer and works closely with research partners and customers to improve the effectiveness and safety of its products for market release. In summary, Alligator Bioscience is a leading company in cancer research and therapy, with an innovative technology platform and highly specialized drugs that have shown promising results. The company is continuously working to develop new and better cancer therapies. Alligator Bioscience ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Alligator Bioscience's Profit Margins

The profit margins of Alligator Bioscience represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Alligator Bioscience's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Alligator Bioscience's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Alligator Bioscience's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Alligator Bioscience’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Alligator Bioscience stock

How much profit has Alligator Bioscience made this year?

Alligator Bioscience has made -117.12 M SEK this year.

How has the profit developed compared to last year?

The profit has increased by -52.89% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Alligator Bioscience publish its earnings?

Alligator Bioscience publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Alligator Bioscience?

The profits of Alligator Bioscience are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Alligator Bioscience?

You can learn more about the earnings of Alligator Bioscience by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Alligator Bioscience pay?

Over the past 12 months, Alligator Bioscience paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Alligator Bioscience is expected to pay a dividend of 0 SEK.

What is the dividend yield of Alligator Bioscience?

The current dividend yield of Alligator Bioscience is .

When does Alligator Bioscience pay dividends?

Alligator Bioscience pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Alligator Bioscience?

Alligator Bioscience paid dividends every year for the past 0 years.

What is the dividend of Alligator Bioscience?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Alligator Bioscience located?

Alligator Bioscience is assigned to the 'Health' sector.

Wann musste ich die Aktien von Alligator Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Alligator Bioscience from 9/13/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 9/13/2024.

When did Alligator Bioscience pay the last dividend?

The last dividend was paid out on 9/13/2024.

What was the dividend of Alligator Bioscience in the year 2023?

In the year 2023, Alligator Bioscience distributed 0 SEK as dividends.

In which currency does Alligator Bioscience pay out the dividend?

The dividends of Alligator Bioscience are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Alligator Bioscience

Our stock analysis for Alligator Bioscience Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Alligator Bioscience Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.